• 1.

    Kasiske BL, Chakkera HA, Louis TA, Ma JZ: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11(10):19107.

    • Search Google Scholar
    • Export Citation
  • 2.

    Pascual J, Quereda C, Zamora J, Hernandez D: Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transpl 2004; 78(10):154856.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, et al..: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil—a prospective randomized study. Steroid Withdrawal Study Group. Transpl 1999; 68(12):186574.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H: Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transpl 2000; 70(9):13529.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Cole E, Landsberg D, Russell D, Zaltzman J, Kiberd B, Caravaggio C, et al..: A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transpl 2001; 72(5):84550.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Elias TJ, Bannister KM, Clarkson AR, Russ GR, Mathew TH, Barratt LJ, et al..: Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression. Clin Transpl 2000; 14(2):15761.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O, Jr.: Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transpl 2003; 76(9):13319.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, et al..: Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006; 148(6):8138.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, et al..: Prednisone-free maintenance immunosuppression—a 5-year experience. Am J Transpl 2005; 5(10):24738.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A: Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transpl 2003; 3(3):30611.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J: A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transpl 2008; 8(2):30716.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Meier-Kriesche HU, Magee JC, Kaplan B. Trials and tribulations of steroid withdrawal after kidney transplantation. Am J Transpl 2008; 8(2):2656.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Hricik DE. Comparing early withdrawal or avoidance of steroids with standard steroid therapy in kidney transplant recipients. Nat Clin Pract Nephrol 2008; 4(7):3601.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P: A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248(4):56477.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, et al..: Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transpl 2008; 8(5):9849.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Pascual J, Zamora J, Galeano C, Royuela A, Quereda C: Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009; (1):CD005632.

    • Search Google Scholar
    • Export Citation
  • 17.

    Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A: Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transpl 2007; 7(8):194853.

    • Crossref
    • Search Google Scholar
    • Export Citation

…But Not All Patients Should be Steroid-Free Posttransplant

Restricted access
Save